New drug aims to ease bulging eyes in thyroid disease patients

NCT ID NCT06557850

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times

Summary

This study tests a medicine called Lu AG22515 in 20 adults with moderate-to-severe thyroid eye disease, an autoimmune condition that causes eye swelling and bulging. The main goal is to see if the treatment reduces bulging eyes over 24 weeks. Researchers will also check how the drug moves through the body and its safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Diagnostic-Consultative Center Alexandrovska

    Sofia, 1431, Bulgaria

  • Jagiellonian University Medical College

    Krakow, Lesser Poland Voivodeship, 30-688, Poland

  • Uniewrsyteckie Centru Kliniczne

    Katowice, 40-514, Poland

  • UnivCentrum Zdrowia MDM EB GROUP Sp.zo.o

    Warsaw, 00-189, Poland

  • University Clinical Center of The Republic Of Srpska

    Banja Luka, Republika Srpska, 78000, Bosnia and Herzegovina

  • University Specialized Hospital for Active Treatment in Endocrinology (USHATE) "Acad. Ivan Penchev"

    Sofia, 1431, Bulgaria

Conditions

Explore the condition pages connected to this study.